Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate

被引:164
作者
Peng, Q [1 ]
Soler, AM
Warloe, T
Nesland, JM
Giercksky, KE
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Univ Oslo, Norwegian Radium Hosp, Dept Surg Oncol, N-0310 Oslo, Norway
关键词
basal cell carcinoma; photodynamic therapy; methyl; 5-aminolevulinate; porphyrin; fluorescence; CCD camera;
D O I
10.1016/S1011-1344(01)00173-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topical photodynamic therapy (PDT) of superficial basal cell carcinoma (BCC) with 5-aminolevulinic acid (ALA) has achieved promising clinical results. However, the efficacy of this therapy for thick BCC is dramatically decreased by a limited diffusion of hydrophilic ALA into the tumor. Lipophilic esters of ALA may enhance their penetration into the lesion. In this randomized, open clinical study, microscopic fluorescence photometry incorporating a li.-ht-sensitive thermo-electrically cooled charge-coupled device (CCD) camera was employed to investigate the penetration of methyl 5-aminolevulinate-induced porphyrin fluorescence in thick BCC lesions. Both the distribution pattern and the amount of porphyrins in 32 lesions of 16 patients were studied after topical application of 16, 80 or 160 mg/g of methyl 5-aminolevulinate for 3 or 18 h. A highly selective and homogeneous distribution of methyl 5-aminolevulinate-induced porphyrin fluorescence was seen in all lesions studied, with much less fluorescence in the adjacent normal skin tissues. In lesions of up to 2 nun thickness the application of 160 mg/g methyl 5-aminolevulinate for 3 h showed the highest ratio of porphyrin fluorescence depth to tumor depth (0.98 +/-0.04), thus providing a biologic rationale for a clinical PDT trial with this regimen. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:140 / 145
页数:6
相关论文
共 26 条
[1]   Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies [J].
Allison, RR ;
Mang, TS ;
Wilson, BD .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1998, 17 (02) :153-163
[2]   Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures [J].
Casas, A ;
Batlle, AMD ;
Butler, AR ;
Robertson, D ;
Brown, EH ;
MacRobert, A ;
Riley, PA .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1525-1532
[3]   Photodynamic therapy [J].
Dougherty, TJ ;
Gomer, CJ ;
Henderson, BW ;
Jori, G ;
Kessel, D ;
Korbelik, M ;
Moan, J ;
Peng, Q .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :889-905
[4]  
Fritsch C, 1998, PHOTOCHEM PHOTOBIOL, V68, P218
[5]   Basal and squamous cell carcinoma [J].
Garner, KL ;
Rodney, WM .
PRIMARY CARE, 2000, 27 (02) :447-+
[6]  
Gaullier JM, 1997, CANCER RES, V57, P1481
[7]  
Gerscher S, 2000, PHOTOCHEM PHOTOBIOL, V72, P569, DOI 10.1562/0031-8655(2000)072<0569:COTPAP>2.0.CO
[8]  
2
[9]   Photodynamic therapy in dermatology [J].
Kalka, K ;
Merk, H ;
Mukhtar, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :389-413
[10]   PHOTODYNAMIC THERAPY WITH ENDOGENOUS PROTOPORPHYRIN .9. BASIC PRINCIPLES AND PRESENT CLINICAL-EXPERIENCE [J].
KENNEDY, JC ;
POTTIER, RH ;
PROSS, DC .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1990, 6 (1-2) :143-148